Upper gastrointestinal bleeding in coronavirus disease 2019 patients

被引:1
|
作者
Mauro, Aurelio [1 ,2 ]
De Grazia, Federico [2 ]
Anderloni, Andrea [2 ]
Di Sabatino, Antonio [1 ]
机构
[1] Univ Pavia, Dept Internal Med 1, Pavia, Italy
[2] Univ Pavia, Gastroenterol & Endoscop Unit, Fdn IRCCS Policlin San Matteo, Pavia, Italy
关键词
coronavirus disease 2019; gastrointestinal symptoms; peptic ulcer; upper gastrointestinal bleeding; CLINICAL CHARACTERISTICS; RISK-FACTORS; COVID-19; MANAGEMENT; PROPHYLAXIS; HEMORRHAGE; ENDOSCOPY; MORTALITY;
D O I
10.1097/MOG.0000000000000859
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review Upper gastrointestinal bleeding (UGIB) has significant morbidity and UGIB cases have been described in coronavirus disease 2019 (COVID-19) patients. Management of this condition can be challenging considering both the possible severe COVID-19-related pneumonia as well as the risk of the virus spreading from patients to health operators. The aim of this paper is to review the most recent studies available in the literature in order to evaluate the actual incidence of UGIB, its clinical and endoscopic manifestations and its optimal management. Recent findings UGIB has an incidence between 0.5% and 1.9% among COVID-19 patients, and it typically presents with melena or hematemesis. Peptic ulcers are the most common endoscopic findings. High Charlson Comorbidity Index (CCI), dialysis, acute kidney injury and advanced oncological disease increase the risk for UGIB. Although anticoagulants are commonly used in COVID-19 patients they are not associated with an increased incidence of UGIB. Conservative management is a common approach that results in similar outcomes compared to upper GI endoscopic treatment. Apparently, UGIB in COVID-19 seems not have a detrimental effect and only one study showed an increased mortality in those who developed UGIB during hospitalization. Summary Incidence of UGIB in COVID-19 patients is similar to that of the general population. Despite the widespread use of anticoagulants in these patients, they are not associated with an increased risk of UGIB. Conservative management could be an effective option, especially for patients that are at risk of intubation.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 50 条
  • [42] Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?
    Lewandowski, Konrad
    Kaniewska, Magdalena
    Rosolowski, Mariusz
    Tworek, Adam
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2022, 17 (03): : 219 - 226
  • [43] Upper gastrointestinal bleeding
    Martins, Noel B.
    Wassef, Wahid
    CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (06) : 612 - 619
  • [44] Upper Gastrointestinal Bleeding
    Vidyut Bhatia
    Rakesh Lodha
    The Indian Journal of Pediatrics, 2011, 78 : 227 - 233
  • [45] UPPER GASTROINTESTINAL BLEEDING
    PATTERSON, M
    JOURNAL OF THE MISSISSIPPI STATE MEDICAL ASSOCIATION, 1974, 15 (11): : 469 - 475
  • [46] Upper Gastrointestinal Bleeding
    Feinman, Marcie
    Haut, Elliott R.
    SURGICAL CLINICS OF NORTH AMERICA, 2014, 94 (01) : 43 - +
  • [47] Upper Gastrointestinal Bleeding
    Bhatia, Vidyut
    Lodha, Rakesh
    INDIAN JOURNAL OF PEDIATRICS, 2011, 78 (02): : 227 - 233
  • [48] Upper Gastrointestinal Bleeding
    Costable, Nicholas J.
    Greenwald, David A.
    CLINICS IN GERIATRIC MEDICINE, 2021, 37 (01) : 155 - 172
  • [49] Upper Gastrointestinal Bleeding
    Patel, Vihas
    Nicastro, Jeffrey
    CLINICS IN COLON AND RECTAL SURGERY, 2020, 33 (01) : 42 - 44
  • [50] Upper gastrointestinal bleeding?
    Halkic, N
    Scholl, B
    Gintzburger, D
    Bouchardy, J
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (07) : 246 - 246